Sign up now!
Don't show this again
Sweepstakes Rules
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

Featured Video Play Icon

How close are we to having a Strep suis vaccine for pigs?

Although antibiotics provide a treatment option for Streptococcus suis — a common, widespread bacterium in swine — long-term management hinges on an effective vaccine.

Add in the prospect of growing limitations on antibiotic use and it’s increasingly important to focus on controlling Strep suis, as well as other pathogens, said Mariela Segura, PhD, immunologist in the pathology and microbiology department at the University of Montreal.

Today, there is no commercial Strep suis vaccine available. Autogenous vaccines are an option, but they’ve produced very mixed results.

More research is needed in all areas. “We need to study the etiology of the disease,” she told Pig Health Today. “We need to monitor the pathogen and better understand how it induces disease and how the host reacts.”

Adding to the challenge are the numerous Strep suis serotypes, or a mix of serotypes, circulating among swine herds. The greatest difference is found between serotypes in North America and those in Europe and Asia, which Segura said are more virulent and present more zoonotic risks. While no more than 10% of the Strep suis in the US can be linked to Europe and Asia strains, it’s important to monitor for any increases or change.

“A vaccine could help protect against different serotypes, but we need more research to identify a vaccine candidate that provides universal coverage,” Segura said.

Another challenge in developing a Strep suis vaccine is to find the right adjuvant to provoke an effective immune response, as well as ensure that it’s safe.

“If we want to vaccinate piglets, we also need to know more about maternal antibodies and the (vaccination) window that we have,” Segura added.

Meanwhile, she acknowledged that North American swine producers and veterinarians have sound protocols in place to dilute the Strep suis impact. Some of these include general biosecurity practices, disinfecting facilities between pig groups and hygiene procedures such as wearing gloves when handling infected pigs.

“Eventually a vaccine is the ideal tool to control this disease,” Segura concluded. “We’re making progress step by step.”



Posted on March 26, 2018

tags: ,
  • Strep suis continuously challenges US herds

    It’s not unrealistic to say that if you checked the nasal cavities or tonsils of any group of pigs, you would find Strep suis. It is on virtually every hog farm.

  • Iowa scientists focused on diagnosing, managing Streptococcus suis in pigs

    Multi-disciplinary collaboration by academia, industry partners and the veterinary community is improving the diagnostics for and management of S. suis.

  • Watch your Strep: Keep your guard up for this evolving bacterium

    Few things remain the same for long on a hog farm. By the very nature of today’s production system, pigs are continuously moving on or off a site. One thing that remains constant is Strep suis.

  • Gebhart: Cracking the Strep suis code

    Streptococcus suis (Strep suis) is becoming more prevalent and more complex in US swine herds. The coccoid-shaped, Gram-positive bacterium is also a zoonotic disease, capable of transmission from pigs to humans.

You must be logged in to edit your profile.

Share It
Looking at individual “pieces of the puzzle” means farm owners can evaluate the pros and cons of Mycoplasma elimination programs and come to a practical solution, says veterinarian David A. Baumert.

Click an icon to share this information with your industry contacts.
Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.